3D Cell Culture Market to Surpass US$ 4,123 Million at a CAGR of 15.28% by 2027

PRESS RELEASE

Published April 17, 2023

According to the latest report by IMARC Group “3D Cell Culture Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global 3D cell culture market reached a value of US$ 1,746 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 4,123 Million by 2027, exhibiting a CAGR of 15.28% during 2022-2027. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

A three-dimensional (3D) cell culture refers to an in vitro technique used for growing biological cells in an artificially created environment. It offers an advanced and vigorous platform for analyzing complex biological processes and mimicking the activity, structure, and microenvironment of the in-vivo tissues. As a result, it finds applications in stem cell therapies, drug screening, regenerative medicine, neuroscience, cancer research, and cell biology.

Request for a free sample copy of this report: https://www.imarcgroup.com/3d-cell-culture-market/requestsample

3D Cell Culture Market Trends and Drivers:

The rising geriatric population, which is more vulnerable to chronic medical disorders, represents one of the key factors driving the market. In addition, the increasing demand for personalized medicines among patients is positively influencing the market. Furthermore, the growing need for effective alternatives to animal testing, along with the development of microfluidics-based 3D cell cultures with enhanced cell viability, proliferation, and differentiation, is offering lucrative growth opportunities to industry investors. Moreover, extensive research and development (R&D) activities in the field of biotechnology are anticipated to propel market growth.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product:

Scaffold-Based Platforms
Scaffold-Free Platforms
Microchips
Bioreactors
Others

Breakup by Application:

Cancer Research
Stem Cell Research
Drug Discovery
Regenerative Medicine
Others

Breakup by End User:

Biotechnology and Pharmaceutical Companies
Contract Research Laboratories
Academic Institutes
Others

Market Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Competitive Landscape with Key Player:

3D Biotek LLC
Advanced Biomatrix Inc.
Avantor Inc.
CN Bio Innovations Limited
Corning Incorporated
Emulate Inc.
InSphero AG
Lonza Group AG
Merck KGaA
Promocell GmbH
Synthecon Inc
Thermo Fisher Scientific Inc.

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=4527&flag=C

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA